PIERIANDX
PierianDx is catalyzing global adoption of genomic sequencing in healthcare by empowering physicians in the laboratory and clinic to more effectively diagnose and treat patients with cancer and other complex diseases. PierianDx’s industry-leading genomic SaaS solutions, CAP and CLIA accredited laboratory, and shared knowledgebase are used by health systems, cancer centers and commercial laboratories worldwide driving the most integrated approach across the clinical care spectrum. From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient’s bedside, PierianDx has rapidly become the trusted source of ‘wisdom’ in every advanced genomic report.
PIERIANDX
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2014-01-01
Address:
St Louis, Missouri, United States
Country:
United States
Website Url:
http://www.pieriandx.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
73.95 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Google Font API Google Tag Manager Google Analytics SSL By Default Font Awesome Global Site Tag IPv6
Similar Organizations
bioPmed
bioPmed is the Italian innovation cluster dedicated to life sciences and healthcare.
Lucence Health
Lucence Health is a liquid biopsy company detecting the hallmarks of cancer for earlier detection and targeted treatment.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-10-12 | Tute Genomics | Tute Genomics acquired by PierianDx | N/A |
Investors List
Inova Health System
Inova Health System investment in Venture Round - PierianDx
SJF Ventures
SJF Ventures investment in Venture Round - PierianDx
RTI International
RTI International investment in Venture Round - PierianDx
ATW Partners
ATW Partners investment in Venture Round - PierianDx
Health Catalyst Capital
Health Catalyst Capital investment in Venture Round - PierianDx
OrbiMed
OrbiMed investment in Venture Round - PierianDx
ARUP Laboratories
ARUP Laboratories investment in Series B - PierianDx
RTI International
RTI International investment in Series B - PierianDx
SJF Ventures
SJF Ventures investment in Series B - PierianDx
Health Catalyst Capital
Health Catalyst Capital investment in Series B - PierianDx
Official Site Inspections
http://www.pieriandx.com Semrush global rank: 3.6 M Semrush visits lastest month: 3.56 K
- Host name: server-18-160-18-57.iad12.r.cloudfront.net
- IP address: 18.160.18.57
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "PierianDx"
PierianDx - Crunchbase Company Profile & Funding
PierianDx is catalyzing global adoption of genomic sequencing in healthcare by empowering physicians in the laboratory and clinic to more effectively diagnose and treat patients with cancer and other complex diseases.See details»
PierianDx Company Profile | Management and Employees List
Founded in 2014, PierianDx is focused on advancing cancer diagnostics and making targeted therapeutics more accessible to healthcare systems, laboratories, and patients worldwide. Its …See details»
About Us - PierianDx
Velsera is founded in January 2023 through the merger of three leading precision medicine companies – Pierian Dx in the clinical diagnostics space, Seven Bridges in the life science …See details»
Pieriandx, Inc. Company Profile | Creve Coeur, MO | Competitors ...
Pieriandx, Inc. D&B Business Directory HOME / BUSINESS DIRECTORY / PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES / COMPUTER SYSTEMS DESIGN AND …See details»
PierianDx - Overview, News & Similar companies | ZoomInfo.com
Oct 19, 2022 Who is PierianDx. Founded in 2014, PierianDx is focused on advancing cancer diagnostics and making targeted therapeutics more accessible to healthcare systems, labor …See details»
PierianDx - Contacts, Employees, Board Members, Advisors
Organization. PierianDx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... PierianDx has 5 current employee profiles, including …See details»
PierianDx, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore PierianDx, Inc. with its drug pipeline, therapeutic area, technology platform, 4 news.See details»
PierianDx Forms Strategic Partnership with Leading Research and ...
The PierianDx Partner Sharing Network includes more than 50 members that utilize shared genomic data to target patient-specific diagnosis and treatments for cancers and hereditary …See details»
PierianDx - Funding, Financials, Valuation & Investors - Crunchbase
PierianDx is funded by 11 investors. Inova Health System and SJF Ventures are the most recent investors. PierianDx has a post-money valuation in the range of $100M to $500M as of Nov 2, …See details»
Working At PierianDx: Company Overview and Culture - Zippia
Mar 14, 2024 From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient's bedside, PierianDx has rapidly become the …See details»
Our Technology - PierianDx | Enabling Personalized Medicine
PierianDx offers the right mix of software, service and support to accelerate your precision medicine program. PierianDx’s Clinical Genomics KnowledgeSpace automatically cultivates …See details»
PierianDx Careers and Employment | Indeed.com
PierianDx’s industry-leading genomic SaaS solutions, CAP and CLIA accredited laboratory, and shared knowledgebase are used by health systems, cancer centers and commercial …See details»
Summa Equity acquires PierianDx - 2023-01-12 - Crunchbase
Jan 12, 2023 PierianDx PierianDx is catalyzing global adoption of genomic sequencing in healthcare Acquiring Organization: Summa Equity Summa Equity is a private equity firm that …See details»
PierianDx Closes up to $47.5 Million of Growth Capital
ST. LOUIS, MO – November 2, 2021—PierianDx, the global leader in clinical genomics knowledge announced that it closed on $30 million of new growth capital including equity …See details»
PierianDx Launches Clinical Genomics Services to Accelerate …
PierianDx, the leading genomics technology company that enables precision medicine, announced today a full range of expanded services to support adoption of the company’s …See details»
PierianDx Closes up to $47.5 Million of Growth Capital
Nov 2, 2021 PierianDx is a partner in precision medicine, enabling clinicians and medical facilities to advance clinical genomics programs and modernize patient care.See details»
PierianDx - Updates, News, Events, Signals & Triggers - Crunchbase
PierianDx may be growing as it is frequently mentioned as a key player in the rapidly expanding next-generation sequencing market, which is characterized by a high compound annual …See details»
Pierian News and Blog | Wisdom in Every Report
PierianDx Forms Strategic Partnership with Leading Research and Technical Services Organization RTI International. PierianDx, the leading genomics technology companythat …See details»
PierianDx Reviews: What Is It Like to Work At PierianDx?
Jun 20, 2024 PierianDx has an overall rating of 3.8 out of 5, based on over 81 reviews left anonymously by employees. 78% of employees would recommend working at PierianDx to a …See details»